Alpha-Emitter Radium-223 Induces STING-Dependent Pyroptosis to Trigger Robust Antitumor Immunity
Overview
Authors
Affiliations
Radium-223 ( Ra) is the first-in-class alpha-emitter to mediate tumor eradication, which is commonly thought to kill tumor cells by directly cleaving double-strand DNA. However, the immunogenic characteristics and cell death modalities triggered by Ra remain unclear. Here, it is reported that the Ra irradiation induces the pro-inflammatory damage-associated molecular patterns including calreticulin, HMGB1, and HSP70, hallmarks of tumor immunogenicity. Moreover, therapeutic Ra retards tumor progression by triggering pyroptosis, an immunogenic cell death. Mechanically, Ra-induced DNA damage leads to the activation of stimulator of interferon genes (STING)-mediated DNA sensing pathway, which is critical for NLRP3 inflammasome-dependent pyroptosis and subsequent DCs maturation as well as T cell activation. These findings establish an essential role of STING in mediating alpha-emitter Ra-induced antitumor immunity, which provides the basis for the development of novel cancer therapeutic strategies and combinatory therapy.
Maharaj M, Perrone E, Wirtz R, Heslop L, Govender T, Korowlay N Cancers (Basel). 2025; 17(3).
PMID: 39941843 PMC: 11815733. DOI: 10.3390/cancers17030476.
Radiopharmaceuticals and their applications in medicine.
Zhang S, Wang X, Gao X, Chen X, Li L, Li G Signal Transduct Target Ther. 2025; 10(1):1.
PMID: 39747850 PMC: 11697352. DOI: 10.1038/s41392-024-02041-6.
Colangelo N, Gerber N, Vatner R, Cooper B Front Pharmacol. 2024; 15:1383000.
PMID: 38659582 PMC: 11039815. DOI: 10.3389/fphar.2024.1383000.
Engineering materials for pyroptosis induction in cancer treatment.
Liu J, Chen T, Liu X, Li Z, Zhang Y Bioact Mater. 2023; 33:30-45.
PMID: 38024228 PMC: 10654002. DOI: 10.1016/j.bioactmat.2023.10.027.